Dentsply Int'l (XRAY) Reports In-Line Q2 EPS, Sales Miss; Guides EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
DENTSPLY International (XRAY) PT Lowered to $66 at Stifel
August 10, 2017 7:21 AM EDTStifel lowered its price target on DENTSPLY International (NASDAQ: XRAY) to $66.00 (from $70.00) while maintaining a Buy rating. Dentsplys results disappointed and the 2017 EPS revision (midpoint lowered by $0.15 to $2.70) was greater than anticipated. Weak 2Q17 results reflected only modest inventory normalization, which when coupled... More
